Assignee
ABT HOLDING CO
US·20 granted patents·23 pending applications·166 citations·filing 2000–2024
Top patents by PatentIndex Score
43 records- 0198US7659118B2Multipotent adult stem cellsABT HOLDING CO·Filed 2005·Granted Feb 9, 2010·92 cites·12 claims
- 0294US7838289B2Assay utilizing multipotent adult stem cellsABT HOLDING CO·Filed 2002·Granted Nov 23, 2010·50 cites·7 claims
- 0388US10967006B2Stem cells for wound healingABT HOLDING CO·Filed 2016·Granted Apr 6, 2021·7 cites·17 claims
- 0483US11197889B2Immunomodulatory properties of multipotent adult progenitor cells and uses thereofABT HOLDING CO·Filed 2017·Granted Dec 14, 2021·1 cites·23 claims
- 0581US10272109B2Organs for transplantationABT HOLDING CO·Filed 2018·Granted Apr 30, 2019·3 cites·18 claims
- 0680US10583202B2Homologous recombination in multipotent adult progenitor cellsABT HOLDING CO·Filed 2017·Granted Mar 10, 2020·1 cites·11 claims
- 0779US11566834B2Apparatus and method for cryostorage and manipulation of a plurality of container unitsABT HOLDING CO·Filed 2020·Granted Jan 31, 2023·1 cites·11 claims
- 0879US10758570B2Modulation of splenocytes in cell therapyABT HOLDING CO·Filed 2018·Granted Sep 1, 2020·1 cites·15 claims
- 0977US2024247859A1Apparatus and method for cryostorage and manipulation of a plurality of container unitsABT HOLDING CO·Filed 2024·Application pending·0 cites
- 1076US7842792B2Compositions and methods for non-targeted activation of endogenous genesABT HOLDING CO·Filed 2002·Granted Nov 30, 2010·1 cites·13 claims
- 1175US11071752B2Organs for transplantationABT HOLDING CO·Filed 2019·Granted Jul 27, 2021·1 cites·19 claims
- 1275US7420044B1Nucleic acid and protein homologs and uses thereofABT HOLDING CO·Filed 2002·Granted Sep 2, 2008·7 cites·32 claims
- 1375US2023131225A1Modulation of Microglia ActivationABT HOLDING CO·Filed 2022·Application pending·0 cites
- 1474US2021346429A1Immunomodulatory properties of multipotent adult progenitor cells and uses thereofABT HOLDING CO·Filed 2021·Application pending·0 cites
- 1573US2023135156A1Apparatus and method for cryostorage and manipulation of a plurality of container unitsABT HOLDING CO·Filed 2022·Application pending·0 cites
- 1669US7767454B2Methods for mutating genes in cells using insertional mutagenesisABT HOLDING CO·Filed 2002·Granted Aug 3, 2010·1 cites·17 claims
- 1767US7569220B2Compositions and methods for non-targeted activation of endogenous genesABT HOLDING CO·Filed 2003·Granted Aug 4, 2009·0 cites·16 claims
- 1866US2021228626A1Immunomodulatory properties of multipotent adult progenitor cells and uses thereofABT HOLDING CO·Filed 2021·Application pending·0 cites
- 1965US11918609B2Stem cells for wound healingABT HOLDING CO·Filed 2021·Granted Mar 5, 2024·0 cites·15 claims
- 2065US7785831B2Compositions and methods for non-targeted activation of endogenous genesABT HOLDING CO·Filed 2005·Granted Aug 31, 2010·0 cites·15 claims
- 2165US2021205359A1Immunomodulatory properties of multipotent adult progenitor cells and uses thereofABT HOLDING CO·Filed 2021·Application pending·0 cites
- 2264US9096520B2Tricyclic ideno-pyrrole derivatives as serotonin receptor modulatorsABT HOLDING CO·Filed 2014·Granted Aug 4, 2015·0 cites·2 claims
- 2364US2021299185A1Mapc treatment of brain injuries and diseasesABT HOLDING CO·Filed 2021·Application pending·0 cites
- 2463US2022110982A1Mapc treatment of brain injuries and diseasesABT HOLDING CO·Filed 2021·Application pending·0 cites
- 2563US2022118026A1Mapc treatment of brain injuries and diseasesABT HOLDING CO·Filed 2021·Application pending·0 cites
- 2662US7972853B2Compositions and methods for making mutations in cell lines and animalsABT HOLDING CO·Filed 2003·Granted Jul 5, 2011·0 cites·15 claims
- 2762US2010010196A1Compositions and methods for non-targeted activation of endogenous genesABT HOLDING CO·Filed 2009·Application pending·0 cites
- 2862US2020390821A1Modulation of splenocytes in cell therapyABT HOLDING CO·Filed 2020·Application pending·0 cites
- 2960US7419828B2Compositions and methods for non-targeted activation of endogenous genesABT HOLDING CO·Filed 2000·Granted Sep 2, 2008·0 cites·2 claims
- 3059US2019048314A1Modulation of AngiogenesisABT HOLDING CO·Filed 2018·Application pending·0 cites
- 3155US2014206672A1Thiophenyl and pyrrolyl azepines as serotonin 5-ht2c receptor ligands and uses thereofABT HOLDING CO·Filed 2014·Application pending·0 cites
- 3254US2023181651A1Treatment of virus-induced acute respiratory distress syndromeABT HOLDING CO·Filed 2021·Application pending·0 cites
- 3351US2011177595A1Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived ThereofABT HOLDING CO·Filed 2011·Application pending·0 cites
- 3450US2011206647A1Modulation of AngiogenesisABT HOLDING CO·Filed 2011·Application pending·0 cites
- 3550US2011212069A1Modulation of Microglia ActivationABT HOLDING CO·Filed 2011·Application pending·0 cites
- 3649US2011217779A1Compositions and Methods for Non-Targeted Activation of Endogenous GenesABT HOLDING CO·Filed 2011·Application pending·0 cites
- 3748US2020246390A1Multipotent adult projenitor cells for treatment of ichABT HOLDING CO·Filed 2019·Application pending·0 cites
- 3848US2010311612A1Compositions and Methods for Making Mutations in Cell Lines and AnimalsABT HOLDING CO·Filed 2010·Application pending·0 cites
- 3942US9309262B2Thienylindole azepines as serotonin 5-HT2C receptor ligands and uses thereofABT HOLDING CO·Filed 2014·Granted Apr 12, 2016·0 cites·9 claims
- 4041US2018311287A9Modulation of Splenocytes in Cell Therapy for Traumatic Brain InjuryABT HOLDING CO·Filed 2016·Application pending·0 cites
- 4141US2011020292A1Use of Stem Cells to Reduce Leukocyte ExtravasationABT HOLDING CO·Filed 2010·Application pending·0 cites
- 4241US2011020293A1Use of Stem Cells to Reduce Leukocyte ExtravasationABT HOLDING CO·Filed 2010·Application pending·0 cites
- 4335US9284277B2Benzazepines as serotonin 5-HT2C receptor ligands and uses thereofABT HOLDING CO·Filed 2013·Granted Mar 15, 2016·0 cites·21 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →